NBTX Nanobiotix
Company Analysis
Latest News
🔴 Nanobiotix is trading 5.1% down today — immediate catalyst unclear
Nanobiotix is trading 5.1% down at $37.64, with no confirmed fundamental catalyst identified; the move appears most consistent with stock-specific trading,...
🔴 Nanobiotix is trading 5.34% down today amid a broad biotech sector pullback
Nanobiotix is trading 5.34% down at $38.01 today, pressured by a broad pullback in biotechnology stocks and a reversal of the previous session's sector-wide...
🟢 Nanobiotix is trading 5.3% up today amid a broader risk-on rally in U.S. equities
Nanobiotix is trading 5.28% up today at $39.85, appearing to track a broader risk-on rally in U.S. equities despite a lack of company-specific catalysts. •...
🔴 Nanobiotix is trading 5% down today on news-less weakness despite positive biotech tape
Nanobiotix is trading 5% down today at $38.16 on light, news-less weakness despite a positive biotech tape. • The move stands out against a roughly 2% gain in...
🟢 Nanobiotix is trading 10.7% up
Nanobiotix is trading at $39.57, up 10.7% from a comparison close of $35.73 during regular trading. This is a price-action follow-up, so a separate catalyst...
🟢 Nanobiotix is trading 5.6% up today as it rebounds from recent volatility
Nanobiotix is trading 5.6% up at $37.74 as the stock rebounds from yesterday’s decline and recent volatility. • There are no fresh company-specific headlines,...
🔴 Nanobiotix is trading 6.5% down today after a sharp reversal from pre-market gains
Nanobiotix is trading 6.5% down at $35.32 today, reversing earlier pre-market gains as the stock continues to experience significant price swings. • The stock...
🟢 Nanobiotix is trading 5.15% up in pre-market
NBTX is trading at $39.74, up 5.15% in pre-market.
🟢 Nanobiotix is trading 5.6% up today on clinical progress and extended cash runway
Nanobiotix is trading 5.6% up at $41.34 in pre-market, extending a sharp multi-month rebound driven by optimism around its cancer radioenhancer JNJ-1900...
Nanobiotix Surges 7% on Lung Cancer Trial Data — But Can Seven Patients Justify a $2 Billion Valuation?
Shares of Nanobiotix jumped 7.3% to $41.78 on July 10 as investors continued digesting eye-catching Phase 2 results for the company's radiation-boosting...
🟢 Nanobiotix Surges 7.3% Today on New Portzamparc 'Buy' Rating and Continued JNJ-1900 Data Momentum
Nanobiotix is trading 7.3% up today at $41.78. • Portzamparc initiated a 'Buy' rating on the stock today, July 10, 2026, with a target price of €56.00,...
🟢 Nanobiotix is trading 6.26% up in pre-market
NBTX is trading at $41.39, up 6.26% in pre-market.
🔴 NBTX is trading 6.3% down today in a pullback following its recent post-update rally
NBTX is trading at $38.50 (6.3% down) in a pullback as traders reassess valuations following its recent first-quarter 2026 operational and financial update. -...
🔴 NBTX is trading 5.6% down today on profit-taking after a multi-day rally
NBTX is trading 5.6% down at $37.25 in pre-market as the stock pulls back from overbought territory following a strong multi-day rally. • The move appears to...
🟢 NBTX is trading 5.12% up today amid broader market strength and tech momentum
NBTX is trading at $37.80 (+5.12%) following a strong intraday move, likely driven by broader market strength and continued momentum in the stock. • U.S....